Rush C - Search Results

1

The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.

Kremenchutzky M, Morrow S, Rush C. Kremenchutzky M, et al. Among authors: rush c. Expert Opin Drug Saf. 2007 May;6(3):279-88. doi: 10.1517/14740338.6.3.279. Expert Opin Drug Saf. 2007. PMID: 17480177 Review.

2

Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.

Oh J, Gagné-Brosseau MS, Guenette M, Larochelle C, Lemieux F, Menon S, Morrow SA, Poliquin-Lasnier L, Roy-Hewitson C, Rush C, Trudelle AM, Giacomini PS. Oh J, et al. Among authors: rush c. Can J Neurol Sci. 2018 May;45(3):304-312. doi: 10.1017/cjn.2018.7. Can J Neurol Sci. 2018. PMID: 29756588

3

Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta.

Correale J, Rush C, Amengual A, Goicochea MT. Correale J, et al. Among authors: rush c. J Neuroimmunol. 2005 May;162(1-2):173-83. doi: 10.1016/j.jneuroim.2005.02.003. J Neuroimmunol. 2005. PMID: 15833373 Clinical Trial.

4

Aggressive multiple sclerosis: proposed definition and treatment algorithm.

Rush CA, MacLean HJ, Freedman MS. Rush CA, et al. Nat Rev Neurol. 2015 Jul;11(7):379-89. doi: 10.1038/nrneurol.2015.85. Epub 2015 Jun 2. Nat Rev Neurol. 2015. PMID: 26032396 Review.

5

Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis.

Rush CA, Atkins HL, Freedman MS. Rush CA, et al. Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):a029082. doi: 10.1101/cshperspect.a029082. Cold Spring Harb Perspect Med. 2019. PMID: 29610145 Free PMC article. Review.

6

Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.

Bose G, Thebault S, Rush CA, Atkins HL, Freedman MS. Bose G, et al. Mult Scler. 2021 Feb;27(2):167-173. doi: 10.1177/1352458520917936. Epub 2020 May 4. Mult Scler. 2021. PMID: 32364422

7

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis.

Thebault S, Lee H, Bose G, Tessier D, Abdoli M, Bowman M, Berard J, Walker L, Rush CA, MacLean H, Booth RA, Narayanan S, Arnold DL, Tabard-Cossa V, Atkins HL, Bar-Or A, Freedman MS. Thebault S, et al. Ann Clin Transl Neurol. 2020 May;7(5):767-775. doi: 10.1002/acn3.51045. Epub 2020 Apr 18. Ann Clin Transl Neurol. 2020. PMID: 32304358 Free PMC article.

8

The White Matter Rounds experience: The importance of a multidisciplinary network to accelerate the diagnostic process for adult patients with rare white matter disorders.

Huang YT, Giacomini PS, Massie R, Venkateswaran S, Trudelle AM, Fadda G, Sharifian-Dorche M, Boudjani H, Poliquin-Lasnier L, Airas L, Saveriano AW, Ziller MG, Miller E, Martinez-Rios C, Wilson N, Davila J, Rush C, Longbrake EE, Longoni G, Macaron G, Bernard G, Tampieri D, Antel J, Brais B, La Piana R. Huang YT, et al. Among authors: rush c. Front Neurol. 2022 Jul 25;13:928493. doi: 10.3389/fneur.2022.928493. eCollection 2022. Front Neurol. 2022. PMID: 35959404 Free PMC article.

9

Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center.

Walker LAS, Gardner C, Freedman MS, MacLean H, Rush C, Bowman M. Walker LAS, et al. Among authors: rush c. Int J MS Care. 2019 Nov-Dec;21(6):243-248. doi: 10.7224/1537-2073.2017-090. Int J MS Care. 2019. PMID: 31889928 Free PMC article.

10

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation.

Thebault S, Booth RA, Rush CA, MacLean H, Freedman MS. Thebault S, et al. Front Neurosci. 2021 Mar 25;15:654942. doi: 10.3389/fnins.2021.654942. eCollection 2021. Front Neurosci. 2021. PMID: 33841093 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

501 results

Search Page